ABBV vs GOOGL: Which Is the Better Buy?

Side-by-side comparison of AbbVie Inc. and Alphabet Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
AbbVie Inc. ยท Healthcare
$261.70
-1.0% upside to fair value
Med Conviction Grade C High Quality
VS
Alphabet Inc. ยท Communication Services
$342.36
+16.6% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
GOOGL has more upside to fair value (+16.6%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric ABBV GOOGL
Current Price $261.70 $342.36
Fair Value Estimate $259.04 $399.26
Upside to Fair Value -1.0% +16.6%
Market Cap $462.4B $4,143.3B
Forward P/E โ€” โ€”
EV / EBITDA 24.8x 12.9x
Price / Sales 7.2x 9.3x
Price / FCF 23.6x 78.1x
Revenue Growth YoY +10.2% +24.2%
Gross Margin 71.5% 60.9%
Operating Margin 29.3% 33.1%
Return on Equity -136.5% 50.8%
Dividend Yield 2.61% 0.25%
FCF Yield 4.25% 1.28%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
ABBV โ€” AbbVie Inc.
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset aโ€ฆ
GOOGL โ€” Alphabet Inc.
Alphabet is the parent of Google Services (Search, YouTube, Android, Chrome, hardware, and the Play store), Google Cloud, and Other Bets, and it remains one of the highest-quality large-cap franchises in the market, with a TTM gross margin of 60.9%, TTM operating margin of 33.1%, TTM net margin of 54.8%, and a 50.8% return on equity. Revenue growth in the most recent quarter was 24.2% year over yโ€ฆ
Accumulation Zones
Metric ABBV GOOGL
Zone Low $194.28 $299.44
Zone High $220.18 $339.37
In Buy Zone? No No
โ† ABBV Research    GOOGL Research โ†’    All Research